Caffeine as a Cross-Domain Research Perturbation
2026-09-07
Caffeine is a versatile small-molecule perturbation tool for cancer research, energy metabolism modulation, and obesity-related assays. This guide explains how to interpret caffeine phenotypes alongside ALDH2 activator research without confusing broad cellular effects with target-specific evidence.
K+ Channel Blockade and Renal Blood Flow in Sepsis
2026-09-05
This study used complementary isolated-kidney and whole-animal experiments to examine how ATP-sensitive and calcium-activated potassium channels shape renal vascular responses during experimental sepsis. Its central finding is that channel blockade may appear neutral at baseline yet worsen renal blood-flow reductions when combined with norepinephrine or phenylephrine, highlighting the context dependence of vasoactive therapy.
Mouse Tissue Lysis Kit K1038 Workflow
2026-09-05
Mouse Tissue Lysis Kit K1038 provides a direct tissue-to-PCR preparation route for mouse tail, toe, or ear samples, reducing the need for separate genomic DNA extraction and purification. It is intended for research genotyping and DNA analysis workflows only, not diagnostic, clinical, or medical testing.
Dicoumarol Targets IRE1α in ER Stress Liver Injury
2026-09-04
A 2025 Life Sciences study combined molecular docking with an XBP1s activity reporter to identify dicoumarol as an inhibitor of IRE1α signaling. The compound reduced tunicamycin- and carbon tetrachloride-associated endoplasmic reticulum stress and acute liver injury, providing a screening framework that connects target prediction with cellular and animal validation.
C8-HSL Activates PI3K/AKT/ERK in Lung Cancer
2026-09-04
This reference study identifies the bacterial quorum-sensing molecule C8-HSL as a potential regulator of lung cancer cell behavior, linking microbial signaling with proliferation, migration, and invasion. Its results support further investigation of C8-HSL-producing bacteria and host signaling responses in microbial pathogenicity research, while also highlighting important limits in translating cell and animal findings to human disease.
DAMGO for Reproducible MOR Assays
2026-09-03
This scenario-based guide explains how DAMGO, SKU B6621, can support selective µ-opioid receptor signaling research while preventing misinterpretation of viability, proliferation, and cytotoxicity readouts. It connects product specifications with cell-based assay design, storage, data interpretation, and translational pain research.
Lipid Nanoparticle Trafficking and Endosomal Escape
2026-09-03
This study shows that efficient lipid nanoparticle delivery depends not only on cellular uptake but also on whether particles move from peripheral endosomes toward perinuclear lysosomes and releasing compartments. Its spatiotemporal analysis links endolysosomal activity, nutrient state, continuous internalization, and microtubule-associated trafficking to cytosolic cargo release, providing a framework for interpreting why high uptake does not always produce high expression.
Sodium Nitroprusside: A Vascular Control Probe
2026-09-02
Sodium Nitroprusside is a nitric oxide donor that helps researchers isolate vascular smooth muscle function from endothelial and autonomic effects. This article develops a sex-aware assay strategy grounded in telemetry, baroreflex, and ganglionic-blockade findings from an angiotensin II hypertension study.
Carboplatin Workflows for Preclinical Cancer Research
2026-09-02
Build reproducible Carboplatin assays for ovarian and lung cancer models with practical guidance on solubility, dose selection, exposure timing, and combination testing. The workflow connects single-agent cytotoxicity data with comparative regimen logic from a systematic review, helping researchers distinguish genuine activity from assay or interaction artifacts.
Phenytoin and Human Serum PON1 Inhibition
2026-09-01
The reference study evaluated how five antiepileptic drugs, including Phenytoin (5,5-diphenylimidazolidine-2,4-dione), inhibit purified human serum paraoxonase-1 (hPON1) in vitro. Phenytoin produced weaker inhibition than gabapentin, valproic acid, and primidone but stronger inhibition than levetiracetam, with a noncompetitive kinetic pattern that highlights a potentially important enzyme-level consideration in antiepileptic drug research.
Hesperadin: Reading Mitotic Checkpoint Phenotypes
2026-09-01
Hesperadin is an Aurora B kinase inhibitor that reveals how chromosome segregation, histone H3 phosphorylation, and mitotic checkpoint timing are coupled. This guide builds a practical assay framework around the compound and connects its phenotype to regulatory insights from the Plk1–p31comet–MCC pathway.
Cediranib (AZD2171): From Potency to Translation
2026-08-31
Cediranib (AZD2171) offers a powerful way to connect VEGFR signaling, angiogenesis biology, and drug-response measurement. This translational perspective shows how to move beyond potency claims by separating pathway suppression, growth arrest, and cell death in cancer research.
Caspase-4 Colorimetric Assay Kit: Mechanism to Readout
2026-08-30
The Caspase-4 Colorimetric Assay Kit converts LEVD-dependent protease activity into a practical readout for pyroptosis, inflammation, and cell-fate studies. This guide explains how to interpret the signal alongside organelle-targeting research without confusing caspase-4 activity with a direct measure of ER stress or cancer-cell death.
L-Ornithine Workflows for Liver–Brain Metabolism
2026-08-29
Use L-Ornithine as a defined substrate and perturbation reagent for OTC activity, urea-cycle profiling, and liver–brain axis studies. This guide translates recent realgar-toxicity findings into practical aqueous workflows, controls, optimization points, and troubleshooting strategies.
JNJ-10198409 PDGF Receptor Inhibitor Workflows
2026-08-29
Build reproducible biochemical, cellular, migration, and angiogenesis assays around JNJ-10198409, a nanomolar platelet-derived growth factor receptor inhibitor. The workflow combines ATP-competition controls with staged phospho-signaling and phenotype measurements to distinguish pathway suppression from nonspecific toxicity.
458 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page